Tekmira Pharmaceuticals Corp (TKMR) (TKMR)

[Ubertino]

Therefore, we think at this time Tekmira should be valued between $150 and $400 million in market cap. If we look at the table of RNA based biotech companies, we think Tekmira should be worth more than Regulus. Our price target of $12 values Tekmira at $168 million in market cap which we think is conservative.

http://seekingalpha.com/article/1292101-tekmira-an-undervalued-pioneer-in-the-field-of-rnai-therapeutics?source=yahoo